VULVODYNIA TREATMENT DRUG MARKET SET TO SURGE BY 2037

The vulvodynia treatment drug market is predicted to have increased from its value of more than USD 6.9 billion in 2024 to about USD 15.2 billion by the end of 2037. The forecast period (2025–2037) has a compound annual growth rate (CAGR) of 6.8% in this increase. Market growth is being driven by rising awareness of vulvodynia as a chronic pain c